<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02467556</url>
  </required_header>
  <id_info>
    <org_study_id>Helsinki University Hospital</org_study_id>
    <nct_id>NCT02467556</nct_id>
  </id_info>
  <brief_title>Psychological Intervention and Physiotherapy With Medication Improves CRPS Patients Outcome</brief_title>
  <acronym>MultiModCRPS</acronym>
  <official_title>Psychological Intervention and Physiotherapy With Medication Improves CRPS Patients Outcome</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Helsinki University Central Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Helsinki University Central Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      A ten week open label study intervention to evaluate the outcome for a psychological
      intervention combined with physiotherapy and medication with memantine-morphine in 10 CRPS
      patients.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Ten CRPS I patients attended an intervention for 10 weeks. First, the medication was started
      with morphine 10mg adding gradually to 30 mg per day. Then, in addition to morphine,
      memantine 5 mg was started adding the dose gradually up to 40 mg per day if tolerated.
      Physiotherapy and psychological intervention were mostly carried out in a weekly group
      gathering with home exercises that were recorded to a diary. Psychological and physiotherapy
      interventions lasted for eight weeks. A neurological examination was done before and after
      the intervention as well as a separate physiotherapist examination of the hands. Patients
      filled out questionnaires of mood, quality of life, pain, and CRPS descriptions before and
      after the intervention.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>March 2011</start_date>
  <completion_date type="Actual">June 2014</completion_date>
  <primary_completion_date type="Actual">May 2014</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Direction of change in patient reported CRPS symptom discriptors</measure>
    <time_frame>Three months</time_frame>
    <description>Reports of CRPS symptoms</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Direction of change in motor parameters</measure>
    <time_frame>Three months</time_frame>
    <description>Measurements of strength of the hand, the active range of motion in the hand/arm, 9HPT, DASH questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Direction of change in psychological parameters</measure>
    <time_frame>Three months</time_frame>
    <description>Patient scores in BDI, PASS-20, CPAQ</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Direction of change in quality of life</measure>
    <time_frame>Three months</time_frame>
    <description>Patient scores in 15D</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">10</enrollment>
  <condition>CRPS</condition>
  <arm_group>
    <arm_group_label>intervention</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Open label study with psychological intervention and physiotherapy intervention with medication of morphine, memantine for ten weeks (morphine 30mg tbl per day and memantine up to 40mg tbl per day if tolerated).</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Morphine, memantine</intervention_name>
    <description>Morphine up to 30 mg per day orally and memantine up to 40 mg per day orally if tolerated for 10 weeks.</description>
    <arm_group_label>intervention</arm_group_label>
    <other_name>Depolan (morphine), Ebixa (memantine)</other_name>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Psychological intervention</intervention_name>
    <description>To help patients shift perspective from pain and CRPS-symptoms, to increase body awareness, to create vivid imagenary, to increase the use of a CRPS hand with mindfulness exposure exercises, to increase flexibility in behavioral repertoire, to explore the fusion of emotions, automatic cognitions and learned responses and to help patients to integrate new skills in their lives.</description>
    <arm_group_label>intervention</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Physiotherapy intervention</intervention_name>
    <description>Graded motor imagenary with group and individual weekly sessions with daily practices at home.</description>
    <arm_group_label>intervention</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  CRPS type 1 for at least 6 months,

          -  pain NRS 4 or more

        Exclusion Criteria:

          -  major psychiatric or neurological disease
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Eija Kalso, MD, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Professor</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Helsinki University Central Hospital</name>
      <address>
        <city>Helsinki</city>
        <state>HUS</state>
        <zip>00029</zip>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Finland</country>
  </location_countries>
  <reference>
    <citation>Bean DJ, Johnson MH, Kydd RR. The outcome of complex regional pain syndrome type 1: a systematic review. J Pain. 2014 Jul;15(7):677-90. doi: 10.1016/j.jpain.2014.01.500. Epub 2014 Feb 12. Review.</citation>
    <PMID>24530407</PMID>
  </reference>
  <reference>
    <citation>Gustin SM, Schwarz A, Birbaumer N, Sines N, Schmidt AC, Veit R, Larbig W, Flor H, Lotze M. NMDA-receptor antagonist and morphine decrease CRPS-pain and cerebral pain representation. Pain. 2010 Oct;151(1):69-76. doi: 10.1016/j.pain.2010.06.022. Epub 2010 Jul 13.</citation>
    <PMID>20630656</PMID>
  </reference>
  <verification_date>June 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 8, 2015</study_first_submitted>
  <study_first_submitted_qc>June 9, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 10, 2015</study_first_posted>
  <last_update_submitted>June 24, 2015</last_update_submitted>
  <last_update_submitted_qc>June 24, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 25, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Helsinki University Central Hospital</investigator_affiliation>
    <investigator_full_name>Hanna Harno</investigator_full_name>
    <investigator_title>MD, PhD</investigator_title>
  </responsible_party>
  <keyword>CRPS</keyword>
  <keyword>intervention</keyword>
  <keyword>multimodal</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Morphine</mesh_term>
    <mesh_term>Memantine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

